Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duvelisib with Methotrexate in Active Rheumatoid Arthritis
NCT01851707Phase 2Completed
- Sponsor
- Secura Bio
- Start
- Apr 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 11
01
Overview
Phase 2, randomised, double-blind trial of duvelisib in rheumatoid arthritis (RA) (4 arms), sponsored by Secura Bio. Primary endpoint: American College of Rheumatology 20% Improvement Criteria at 12 weeks. Started Apr 2013; status: completed.
02
Drugs
duvelisib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01851707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01851707.